We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Emerging Microbes & Infections

Open for submissions

 

As an international, peer-reviewed journal, Emerging Microbes & Infections (EMI) aims to provide a timely dissemination of research on emerging immunology and microbiology viruses. Research on microbes and infections, especially those associated with increasing biological and clinical significance and pathogenic frequency, are of most interest to the journal. 

The sheer volume and complexity of such information has gone beyond the scale and scope of existing specialty journals, and thus EMI is committed to bridging the gap between scientific communities in developed and developing countries where most of the emerging microbes and infections have occurred in recent years.

Below are special topics published by the journal in recent years. If you find that your current research fits within the scope of this journal, submit your research for publication in EMI.

submit manuscript

CORONAVIRUSES

Emerging and re-emerging coronaviruses, including SARS-CoV, MERS-CoV, and COVID-19.

Research and review articles on the basic, translational and clinical studies related to these coronaviruses.

GO TO COLLECTION

INFLUENZA INFECTIONS

Emerging seasonal and pandemic influenza infections and viruses.

Research reports and high quality reviews on these important emerging viruses.

GO TO COLLECTION

JOURNAL METRICS

1.8M annual downloads/views

2020 Impact Factor 7.163*

2020 CiteScore 11.6**

7 days avg. from submission to first decision

MORE METRICS

ZIKA

Emerging as a major ongoing pandemic worldwide in the last few years.

Novel research reports related to different aspects of Zika epidemics for global researchers.

GO TO COLLECTION

EBOLA

Ebola virus disease in both developing and developed countries in recent years.

Papers published in this area include commentary and original research articles covering drug discovery, passive immune therapy and vaccine development.

GO TO COLLECTION

EV71

Papers on the characterization of EV71, a potentially highly virulent emerging viral infection targeting the pediatric population in Asia.

GO TO COLLECTION

DRUG RESISTANCE AND NOVEL ANTIMICROBIAL AGENTS

Papers on all medically relevant bacteria, viruses, parasites and fungi including epidemiology and surveillance of resistant microbes, mechanisms of action and resistance, detection, treatment practice/strategies, and new drug development.

GO TO COLLECTION

TUBERCULOSIS

Research reports and high quality reviews on TB research including epidemiology, fundamental research, development of new diagnostics and biomarkers, development of new drugs and vaccines, and public health issues related to this important pathogen.

GO TO COLLECTION

HEPATITIS

Updates from the classical emerging infections.

Covering hepatitis viruses in terms of biology, pathogenesis, immune response, therapy, and prevention, with special emphasis on recent progress.

GO TO COLLECTION

Help with your submission

Review the journal's Aims & Scope and read the full instructions for authors before submitting your manuscript.

To help improve your manuscript and prepare it for submission, Taylor & Francis provides a range of editing services. Choose from options such as English Language Editing, which will ensure that your article is free of spelling and grammar errors, Translation, and Artwork Preparation. For more information, including pricing, visit Editing Services.

Review a checklist of what to include in your submission.

*Journal Citation Reports®, Clarivate Analytics, 2021          **CiteScore™ 2021